4''-trans-Hydroxy cilostazol
CAS: 87153-04-6
Ref. 3D-FH23951
| 1mg | Descontinuado | ||
| 2mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado |
Informação sobre produto
Nome:
4''-trans-Hydroxy cilostazol
Sinónimos:
- trans-3,4-Dihydro-6-[4-[1-(4-hydroxycyclohexyl)-1H-tetrazol-5-yl]butoxy]-2(1H)-quinolinoneOPC 13213
Descrição:
Cilostazol is a drug that belongs to the class of antiplatelet agents and is prescribed for the prevention of thrombotic events. Cilostazol has been shown to inhibit platelet aggregation by blocking adenosine diphosphate (ADP) receptors on the platelets. It also inhibits p38, an enzyme involved in apoptosis. This drug has shown to be effective in reducing atherosclerosis and preventing cardiovascular disease, but carries the risk of adverse effects such as gastrointestinal bleeding. The drug is absorbed orally, but can be reconstituted with water if taken with food or milk. Cilostazol has been shown to have a pharmacokinetic profile similar to cilostamide, which is another anti-platelet agent.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
385.46 g/mol
Fórmula:
C20H27N5O3
Pureza:
Min. 95%
InChI:
InChI=1S/C20H27N5O3/c26-16-7-5-15(6-8-16)25-19(22-23-24-25)3-1-2-12-28-17-9-10-18-14(13-17)4-11-20(27)21-18/h9-10,13,15-16,26H,1-8,11-12H2,(H,21,27)
Chave InChI:
InChIKey=KFXNZXLUGHLDBB-UHFFFAOYSA-N
SMILES:
O=C1CCc2cc(OCCCCc3nnnn3C3CCC(O)CC3)ccc2N1
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
